For example, in a study of bladder cancer progression, the genomic and proteomic profiles in association with TP53 show that C1ORF112 has a gene expression fold change corresponding to an increased expression with tumours having mutant TP53, an oncogene involved in driving various cancers [9]. The gene discussed is TP53; the disease is urinary bladder carcinoma.